Sonoma pharmaceuticals to present at trickle research and ld micro investor conferences

Boulder, co / accesswire / march 28, 2024 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced that it will be presenting at two upcoming investor conferences in denver and new york. trickle research spring 2024 microcap conference sonoma will be presenting at the trickle research spring 2024 microcap conference at ball arena in denver, colorado on april 2nd, 2024.
SNOA Ratings Summary
SNOA Quant Ranking